- Market leading precision medium for isolation and expansion of large airway epithelial cells
- Chemically defined, contains no components of animal or human origin
- Fully supplemented, one bottle ready-to-go
Efficient isolation and expansion of large airway epithelial cells.
|Content||500 ml, Frozen medium|
CnT-Prime Airway is a fully defined, animal-component-free medium for the isolation and expansion of large airway epithelial cells.
CnT-PR-A is a chemically defined, low calcium (0.07 mM) medium formulation designed for optimal isolation, expansion, and longevity of primary large airway epithelial cells. It is an evolution and refinement of our previous airway medium CnT-17.
It uses an optimized basal medium with additional trace elements, protective antioxidants, and vitamins. This basal medium is then supplemented with a range of Progenitor Cell Targeted (PCT) growth factors for efficient isolation and extended longevity, and co-factors to improve growth factor binding to membrane-bound receptors.
It is completely free of animal or human-derived components. CnT-PR-A contains purified growth factors, an optimized basal medium to increase cell proliferation, and PCT factors to maximize retention of proliferative progenitor cells, increase longevity, and minimize loss through differentiation. It does not contain phenol-red, or antibiotics / antimycotics.
Large airway cells growing in CnT-PR-A retain deliver extended growth. For differentiation experiments, it is recommended to switch to the CnT-PR-AD differentiation medium.
The medium undergoes a range of QC tests in our lab before being released for sale. Please see the datasheet for details.
It can easily be upgraded for clinical applications. Contact us at email@example.com for further details and pricing.
Thawing, seeding, and passaging protocols are particularly important for optimal cell growth. Please visit our Protocols Page for our recommendations.
Like to try a test sample? Click here for more information.
|ATriple Co-CultureModeloftheHuman RespiratoryTract to Study Immune Modulatory Effects o fLiposomes and Virosomes||Rebecca A. M. Blom, Silvia T. Erni, KristõÂna KrempaskaÂ, Olivier Schaerer, R. Maarten van Dijk, Mario Amacker, Christian Moser, Sean R. R. Hall, Christophe von Garnier, Fabian Blank||2016||Airway|
|Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer||RA Schmid and R-W Peng||2015||Airway|
|Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP||Michael Roth, Christian Pasquali, Daiana Stolz, Michael Tamm||2017||Airway|